3D bioprinting, an additive manufacturing technology, refers to the process of creating 3D structures using live cells. The process uses 3D printing technologies for crating live cells or tissue structures. These structures are used for applications in medical or healthcare. The 3D bioprinted cells or tissues are preserved into the printed construct of different materials.

The global 3D bioprinting market is growing at a significant rate due to the increasing research and devlopment activities, technological advancements and innovations, increasing compliace for drug discovery processes and high demand for tissue and organs for transplantation. The growing stem cell research and increasing adoption of 3D bioprinting in cosmetic industry offer ample growth opportunities for the global 3D bioprinting market.

3D bioprinting technology has gained enormous traction across the globe for production of 3D structures and tissue fabrication. 3D bioprinting is being used to print multiple biological cells, biomolecules and biomaterials into specific spatial strucures. However, the development of complex tissues and fully functional organs still remain a key challenge for 3D bioprinting industry vendors and researchers.

Geographically, North America is the largest market for 3D bioprinting all around the globe. The North American 3D bioprinting market is growing significantly due to technological advancement, increasing research and development activities, and developed healthcare infrastructure. The high healthcare expenditure, growing geriatric population and increasing prevalence of chronic diseases is also supporting the demand for 3D bioprinting especially in pharmaceutical industry. The U.S. is the largest market for 3D bioprinting among all the countries of North America as well as worldwide. The U.S. 3D bioprinting market is growing significantly due to the increasing R&D for tissue engineering and fabrication and technological advancements. The presence of large number of market players, increasing chronic diseases are fueling the demand for 3D bioprinting industry.